Tumor cell-selective apoptosis induction through targeting of KV10.1 via bifunctional TRAIL antibody
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tumor cell-selective apoptosis induction through targeting of KV10.1 via bifunctional TRAIL antibody ; volume:10 ; number:1 ; day:7 ; month:9 ; year:2011 ; pages:1-15 ; date:12.2011
Molecular cancer ; 10, Heft 1 (7.9.2011), 1-15, 12.2011
- Creator
-
Hartung, Franziska
Stühmer, Walter
Pardo, Luis A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-10-109
- URN
-
urn:nbn:de:101:1-2021082121371674072095
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hartung, Franziska
- Stühmer, Walter
- Pardo, Luis A.
- SpringerLink (Online service)
Other Objects (12)
Gene-immunotherapy with TRAIL and bispecific antibody EpCAMxCD3 for the selective induction of apoptosis in advanced pancreatic and prostate cancer
N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
TRAIL and thymocyte apoptosis : not so deadly?
TRAIL-induced apoptosis : between tumor therapy and immunopathology
c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL
Engineering of a bifunctional anti-Kv10.1 antibody for cancer therapy
Bortezomib-mediated sensitization for TRAIL-induced apoptosis in glioblastoma
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis
HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells
Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL
Gene-immunotherapy with TRAIL and bispecific antibody EpCAMxCD3 for the selective induction of apoptosis in advanced pancreatic and prostate cancer
N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
TRAIL and thymocyte apoptosis : not so deadly?
TRAIL-induced apoptosis : between tumor therapy and immunopathology
c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL
Engineering of a bifunctional anti-Kv10.1 antibody for cancer therapy
Bortezomib-mediated sensitization for TRAIL-induced apoptosis in glioblastoma
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis
HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells
Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL
Gene-immunotherapy with TRAIL and bispecific antibody EpCAMxCD3 for the selective induction of apoptosis in advanced pancreatic and prostate cancer
N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
TRAIL and thymocyte apoptosis : not so deadly?
TRAIL-induced apoptosis : between tumor therapy and immunopathology
c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL
Engineering of a bifunctional anti-Kv10.1 antibody for cancer therapy
Bortezomib-mediated sensitization for TRAIL-induced apoptosis in glioblastoma
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis
HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells